SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-016864
Filing Date
2020-07-07
Accepted
2020-07-07 16:13:48
Documents
38
Period of Report
2020-05-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0520_oramedpharma.htm 10-Q 352493
2 CERTIFICATION f10q0520ex31-1_oramed.htm EX-31.1 12691
3 CERTIFICATION f10q0520ex31-2_oramed.htm EX-31.2 9814
4 CERTIFICATION f10q0520ex32-1_oramed.htm EX-32.1 3556
5 CERTIFICATION f10q0520ex32-2_oramed.htm EX-32.2 3356
6 GRAPHIC img_001.jpg GRAPHIC 9378
  Complete submission text file 0001213900-20-016864.txt   1992244

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ormp-20200531.xml EX-101.INS 281563
8 XBRL SCHEMA FILE ormp-20200531.xsd EX-101.SCH 31153
9 XBRL CALCULATION FILE ormp-20200531_cal.xml EX-101.CAL 35702
10 XBRL DEFINITION FILE ormp-20200531_def.xml EX-101.DEF 77729
11 XBRL LABEL FILE ormp-20200531_lab.xml EX-101.LAB 202352
12 XBRL PRESENTATION FILE ormp-20200531_pre.xml EX-101.PRE 137790
Mailing Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 201016232
SIC: 2834 Pharmaceutical Preparations